David Chang (L) and Arie Belldegrun (photo by Jeff Rumans)
Arie Belldegrun and David Chang godfather the $110M launch of a new cell therapy player. And this one is also thinking big
Back in 2015, when Arie Belldegrun and David Chang were running the show at Kite as the biotech raced to a historic approval for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
